Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Division of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Germany.
Eur J Intern Med. 2020 Jul;77:97-104. doi: 10.1016/j.ejim.2020.03.008. Epub 2020 Mar 14.
The percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains debated. Therefore the aim of this large-scale observational multi-center registry was to compare the long-term outcome of CTO patients undergoing different therapeutic approaches comparing successful CTO revascularization either by PCI or coronary artery bypass graft (CABG), failed CTO-PCI and optimal medical therapy (OMT) alone.
A total of 6630 CTO patients were enrolled from two high-volume centers to compare different treatment strategies. All procedures were performed by high-volume CTO operators in tertiary university hospital. Successful CTO-PCI was performed in 3906 patients, failed CTO-PCI in 1479 patients, 412 patients underwent CABG surgery and 833 patients were treated with OMT. During the 5-year follow-up period, 1019 (15%) patients died. Kaplan-Meier analysis unveiled a significantly improved long-term outcome for CTO patients undergoing revascularization either by PCI or by CABG compared to patients with failed CTO-PCI or OMT alone (log-rank P < 0.001). In the multivariate Cox-regression analysis successful CTO-PCI was associated with significantly improved long-term outcome compared to patients under OMT (adj. HR 0.39, 95%CI 0.33-0.45, P < 0.001) or CABG (adj. HR 0.68, 95%CI 0.53-0.86, P = 0.002) independent of clinical confounders encompassing age, BMI, diabetes, kidney function and left ventricular function.
This study showed an improved long-term outcome for CTO revascularization compared to optimal medical therapy, independent from revascularization mode, with the highest survival rate in patients undergoing successful CTO-PCI.
经皮冠状动脉介入治疗(PCI)治疗慢性完全闭塞(CTO)仍然存在争议。因此,本大规模观察性多中心注册研究的目的是比较不同治疗方法的 CTO 患者的长期结果,比较成功的 CTO 血运重建(通过 PCI 或冠状动脉旁路移植术(CABG))、失败的 CTO-PCI 和单纯最佳药物治疗(OMT)的 CTO 患者。
共从两家高容量中心纳入 6630 例 CTO 患者,以比较不同的治疗策略。所有手术均由三级大学医院的高容量 CTO 操作人员进行。3906 例患者成功进行 CTO-PCI,1479 例患者 CTO-PCI 失败,412 例患者接受 CABG 手术,833 例患者接受 OMT 治疗。在 5 年随访期间,有 1019 例(15%)患者死亡。Kaplan-Meier 分析显示,与 CTO-PCI 失败或单纯 OMT 治疗的患者相比,接受 PCI 或 CABG 血运重建的 CTO 患者的长期预后显著改善(对数秩 P <0.001)。在多变量 Cox 回归分析中,与 OMT 治疗(校正 HR 0.39,95%CI 0.33-0.45,P <0.001)或 CABG(校正 HR 0.68,95%CI 0.53-0.86,P = 0.002)相比,成功的 CTO-PCI 与显著改善的长期预后相关,独立于年龄、BMI、糖尿病、肾功能和左心室功能等临床混杂因素。
本研究显示与最佳药物治疗相比,CTO 血运重建的长期预后改善,与血运重建模式无关,成功的 CTO-PCI 患者的生存率最高。